We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
AUM
$324M
AUM Growth
-$19.1M
Cap. Flow
-$15M
Cap. Flow %
-4.62%
Top 10 Hldgs %
68.58%
Holding
184
New
7
Increased
19
Reduced
72
Closed
30

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.04M
2
MRK icon
Merck
MRK
+$1.34M
3
UNP icon
Union Pacific
UNP
+$1.08M
4
IWN icon
iShares Russell 2000 Value ETF
IWN
+$911K
5
PLD icon
Prologis
PLD
+$903K

Sector Composition

Rank Sector Weight
1 Technology 9.39%
2 Financials 6.68%
3 Healthcare 4.39%
4 Industrials 3.89%
5 Consumer Discretionary 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUN icon
176
Sunoco
SUN
$14.2B
-6,191
Closed -$332K
SYK icon
177
Stryker
SYK
$127B
-1,500
Closed -$542K
SYY icon
178
Sysco
SYY
$39.7B
-3,034
Closed -$237K
TDG icon
179
TransDigm Group
TDG
$69.2B
-273
Closed -$390K
UNP icon
180
Union Pacific
UNP
$183B
-4,367
Closed -$1.08M
VTI icon
181
Vanguard Total Stock Market ETF
VTI
$654B
-40
Closed -$11.3K
VUG icon
182
Vanguard Growth ETF
VUG
$216B
-4,278
Closed -$274K
WDAY icon
183
Workday
WDAY
$33.4B
-1,541
Closed -$377K
WST icon
184
West Pharmaceutical
WST
$23.1B
-883
Closed -$265K

Similar funds

Covenant Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Covenant Partners held 184 positions worth $324M, down 5.6% from $344M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Covenant Partners withdrew a net $15M in Q4 2024, closing 30 positions and reducing 72 holdings. Its most notable exit was Merck, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.6% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Covenant Partners opened a new position in Carlyle Group worth $309K.

  • Covenant Partners's largest Q4 2024 buy was Carlyle Group: 6,129 shares worth $309K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q4 2024, an estimated $2.11M increase.
  • Covenant Partners's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $4.04M.
  • Covenant Partners fully exited Merck in Q4 2024, selling an estimated $1.34M.
  • Covenant Partners's ten largest holdings make up 69% of its $324M portfolio in Q4 2024.
  • Covenant Partners opened 7 new positions and closed 30 in Q4 2024.
  • Covenant Partners's portfolio value fell 5.6% quarter-over-quarter to $324M.

Based on Covenant Partners's 13F filing for Q4 2024, filed 14 Feb 2025.